PGC Stock Overview
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Paragon Care Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.48 |
52 Week High | AU$0.49 |
52 Week Low | AU$0.38 |
Beta | 0 |
11 Month Change | 7.78% |
3 Month Change | 14.12% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 27.63% |
Recent News & Updates
Recent updates
Shareholder Returns
PGC | AU Healthcare | AU Market | |
---|---|---|---|
7D | 1.0% | 0.7% | 1.5% |
1Y | n/a | 4.0% | 17.2% |
Return vs Industry: Insufficient data to determine how PGC performed against the Australian Healthcare industry.
Return vs Market: Insufficient data to determine how PGC performed against the Australian Market.
Price Volatility
PGC volatility | |
---|---|
PGC Average Weekly Movement | 5.7% |
Healthcare Industry Average Movement | 5.1% |
Market Average Movement | 8.6% |
10% most volatile stocks in AU Market | 17.3% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: PGC has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: Insufficient data to determine PGC's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 550 | David Collins | www.paragoncare.com.au |
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. It operates through two segments: ParagonCare and CH2. The company offers its for aesthetics, controlle, critical care, diagnostic and scientific, eye care, medical products and consumables, neonatal, orthopaedics service, surgical, technology & connectivity, urology, and veterinary products.
Paragon Care Limited Fundamentals Summary
PGC fundamental statistics | |
---|---|
Market cap | AU$827.65m |
Earnings (TTM) | AU$8.38m |
Revenue (TTM) | AU$2.97b |
98.8x
P/E Ratio0.3x
P/S RatioIs PGC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PGC income statement (TTM) | |
---|---|
Revenue | AU$2.97b |
Cost of Revenue | AU$2.79b |
Gross Profit | AU$176.07m |
Other Expenses | AU$167.69m |
Earnings | AU$8.38m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0051 |
Gross Margin | 5.93% |
Net Profit Margin | 0.28% |
Debt/Equity Ratio | 62.7% |
How did PGC perform over the long term?
See historical performance and comparison